secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0001801170-23-000115
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 2.05, 2.06, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health exits ACO REACH, expects $8M-$10M charges; sees faster path to profitability
--------------------------------------------------------------------------------

- Board decided to exit CMS ACO REACH Program; notice delivered Dec 1, 2023, effective end of 2023 performance year.
- Total charges estimated at $8M to $10M, including $6M non-cash impairment in Q4 2023.
- CEO says no clear line to profitability in ACO REACH; Medicare Advantage business making swifter strides.
- Exit has no impact on ACO REACH beneficiaries; Clover will fulfill 2023 obligations.
- Company expects Adjusted EBITDA profitability for full-year 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000115/0001801170-23-000115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000115/clov-20231130.htm
  HTML page:      https://secwatch.observer/filing/0001801170-23-000115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer